BMJ  2004;329:1299-1300 (4 December), doi:10.1136/bmj.329.7478.1299

Editorial

Benign parotid tumours

Can be removed safely by extra-capsular dissection, a less invasive procedure

All surgical disciplines have moved towards subspecialisation with the development of less invasive procedures and reduction in surgical morbidity. The difficulty with salivary tumours is that they are rare and have a long clinical course that requires follow up data for a decade or more. Prospective randomised trials have therefore not been undertaken, and progress happens slowly, with new generations of surgeons building on the experience of their peers.

Improved methods of assessment (magnetic resonance imaging, computed tomography, ultrasound, and fine needle aspiration biopsy) have had a major impact on salivary gland surgery because of increased confidence in distinguishing benign from malignant tumours. Of discrete lumps, only 5% will prove to be malignant, and over half of these can be recognised on clinical examination alone.¹ The addition of modern techniques for investigation reduces further the risk of inadvertently encountering a malignant neoplasm. This then avoids the traditional "one approach fits all" attitude to parotid surgery.

Most benign parotid tumours are either pleomorphic adenomas (71%) or Warthin's tumours (22%).² Unfortunately pleomorphic adenoma has a reputation for recurrence that has lingered since the 1940s and 50s. The nature of pleomorphic adenoma was then unclear for, as its name implies, it has a variable appearance and so was thought to be a hamartoma rather than a neoplasm. Treatment was by crude enucleation, and in some centres the tumour capsule was even left in situ, with obvious consequences. The reputation of the tumour for recurrence was given further credence in 1958 by Patey and Thackray's work,³ which showed an incomplete capsule through which small buds of tumour protruded. This was the rationale for the traditional superficial parotidectomy. The technique was promoted by Hamilton Bailey and others as a solution to the recurrence problem, which it proved to be. Superficial parotidectomy was adopted universally as the treatment of choice for the discrete parotid lump.

During the early years of debate, through serendipity, Alan Nicholson, a surgeon at the Christie Hospital in Manchester, held a different view. He felt that recurrence was due to inadequate surgical exposure, which leads to rough handling and rupture of the tumour rather than the biological nature of the tumour itself. At this time, parotid tumours were managed under local anaesthesia by an incision made directly over the tumour. In contrast he used wide exposure through a pre-auricular skin flap but then proceeded to a local dissection of the tumour rather than a parotidectomy. By the time the debate was resolved in favour of superficial parotidectomy he had 10 years of data, which showed no increase in the risk of recurrence by the less invasive method, and so he and his successors, Gleave and Hancock, persisted with the technique in isolation from the surgical community.

The recent analysis of this experience, under-pinned by a mean follow up period of 15 years, shows conclusively that local dissection of benign parotid tumours is a safe procedure with recurrence rates of 2%—no more than that with traditional parotidectomy.⁴ The advantage is that minimal surgery produced less morbidity as measured by nerve injury, Frey's syndrome (a disorder characterised by excessive gustatory sweating of the skin overlying the parotid), and the formation of neuromas.⁵ Neither does it cause a deformity of the cheek due to loss of parotid tissue. The Christie data show that 70% of patients with discrete parotid lumps could safely avoid formal parotidectomy.

Surgeons are traditionalists, and the early experience of our peers has coloured current surgical opinion and slowed the introduction of conservative surgery for the benign parotid lump. This situation is now changing, and centres with experience of treating parotid tumours increasingly recognise that benign tumours can be removed safely by techniques much less invasive than a formal parotidectomy.^6-8

Salivary Gland Service, Department of Oral and Maxillofacial Surgery, Guy's, King's and St Thomas's Hospital Trust, London SE1 9RT (mark.mcgurk{at}kcl.ac.uk)

---

Competing interests: None declared.

References

1. McGurk M, Thomas B, Renehan A. Extra capsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer 2003;89: 1610-3.[Medline]
2. Bradley P. General epidemiology and statistics in a defined UK population. In: McGurk M, Renehan A, eds. Controversies in the management of salivary gland disease. Oxford: Oxford University Press 2001: 3-23.
3. Patey DH, Thackray AC. The treatment of parotid tumours in the light of a pathological study of parotid material. Br J Surg 1958;55: 477-87.
4. Leverstein H, van der Wal JE, Tiwari RM, van der Waal I, Snow GB. Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg 1997;84: 399-403.[CrossRef][ISI][Medline]
5. McGurk M, Renehan A, Gleave EN, Hancock BD. Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas. Br J Surg 1996;83: 1747-9.[Medline]
6. Snow G. The surgical approaches to the treatment of parotid pleomorphic adenomas. In: McGurk M, Renehan A, eds. Controversies in the management of salivary gland disease. Oxford: Oxford University Press 2001: 57-66.
7. O'Brien CJ. Current management of benign parotid tumours—the role of limited superficial parotidectomy. Head Neck 2003;25: 946-52.[Medline]
8. Ghosh S, Panarese A, Bull PD, Lee JA. Marginally excised parotid pleomorphic salivary adenomas: risk factors for recurrence and management. A 12.5 year mean follow-up study of histologically marginal excisions. Clin Otolaryngol Allied Sci 2003;28: 262-6.[CrossRef][Medline]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

Treatment of Benign Parotid Neoplasms

David C Howlett
bmj.com, 7 Dec 2004 [Full text]

Extra-capsular dissection vs. superficial parotidectomy for parotid tumours

Orlando Guntinas-Lichius, et al.
bmj.com, 9 Dec 2004 [Full text]

Superficial Parotidectomy: Why change?

Jeremy M Rawlins
bmj.com, 11 Dec 2004 [Full text]

Interstitial Implants for Benign Parotid Tumours

Bruce F Sizer, et al.
bmj.com, 4 Jan 2005 [Full text]